NXTC: Bathi resik saben saham (EPS TTM) NextCure Corp

NextCure, Inc. (NXTC) focuses on discovering new pathways to combat resistant tumors within its R&D framework. This daily price chart of the annual EPS TTM on GURU.Markets illustrates profit dynamics, where -8.73 reflects the current value of the metric. Innovations are based on the FIND platform for identifying hidden targets, while strategic alliances with pharma behemoths accelerate the validation of new antibodies.

NXTC Bathi resik saben saham sajrone 12 wulan pungkasan NextCure, Inc. (04.07.2022 - 12.11.2026)

Ringkesan rincian data analitis NextCure Inc (NXTC)

- rega saham lan prakiraan rega para ahli:

Kutipan saham NextCure, Inc.|NXTC - Konsensus nilai wajar

- informasi kapitalisasi pasar:

Kapitalisasi pasar NextCure, Inc.|NXTC - Rega Tumbas Perusahaan

- rincian valuasi buku bisnis:

Aset Bersih saben Siji Saham NextCure|NXTC - Aset Bersih Perusahaan|Rasio Nilai Pasar marang Nilai Buku nextcure.com|NXTC - Gunggung Aset Perusahaan

- indikator beban kredit lan likuiditas emiten:

- data bathi lan kelipatan valuasi:

NXTC - Bathi sawise mbayar pajeg|Proyeksi bathi mangsa ngarep NextCure, Inc.|NXTC - Nilai perusahaan marang bathi resik|Pangali Forward P/E NextCure|NXTC - Rega marang bathi kanthi panyesuaian wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan NextCure, Inc.|NXTC - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) NextCure|NXTC - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan nextcure.com|NXTC - Dinamika bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep NextCure, Inc.

Pambiji fundamental:NXTC - NextCure, Inc.

Selecting high-quality issuers is based on analyzing a business's ability to generate real income. Annual net income per share measures the portion of profit attributable to a single security, stripping the financial result of the influence of the total issuance volume. For NextCure, Inc. (NXTC), which is developing unique onco-immunological research, this metric reflects the efficiency of monetizing scientific discoveries. By analyzing the current level of rolling earnings per share, an investor assesses business sustainability. The dynamics of this metric allow for the differentiation of long-term growth from one-time cost reductions.

Pesaing utama